The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P
Abstract
Bradykinin (BK) has been proposed as the principal mediator of hypersensitivity reactions (HSR) in patients dialyzed using negatively charged membranes and concomitantly treated with angiotensin-converting enzyme (ACE) inhibitors. We investigated the metabolism of exogenous BK added to the sera of 13 patients dialyzed on an AN69 membrane with a history of HSR (HSR+ patients) and 10 others who did not present such a reaction (HSR- patients) while dialyzed under the same conditions. No significant difference in the t1/2 of BK was found between the patient groups. However, the t1/2 of generated des-Arg9-BK was significantly increased (2.2-fold) in HSR+ patients compared to HSR-subjects. Preincubation of the sera with an ACE inhibitor (enalaprilat) significantly increased the t1/2 of both BK and des-Arg9-BK in both groups. There was no significant difference between the groups with respect to the t1/2 of BK, but there was a significantly greater increase (3.8-fold) in the t1/2 of des-Arg9-BK in HSR+ patients compared to HSR-subjects. The level of serum aminopeptidase P (APP) activity showed a significant decrease in the HSR+ sera when compared to HSR-samples. In HSR- and HSR+ patients, a significant inverse relation (r2 = 0.6271; P < 0.00005) could be calculated between APP activity and des-Arg9-BK t1/2. In conclusion, HSR in hemodialyzed patients who are concomitantly treated with a negatively charged membrane and an ACE inhibitor can be considered as a multifactorial disease in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hypertensive patients who experienced ACEi-angioedema, impaired degradation of bradykinin and des-Arg 9 -bradykinin has been associated with a decreased activity of plasma APP [Adam et al., 2002;Blais et al., 1999;Molinaro et al., 2006].”
From A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor‐induced angioedema (2011) · cites this paper as Blais et al., 1999
Citations
Cites
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 953
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz, W., Wiemer, G., Gohlke, P., Unger, T., & Schölkens, B. A. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06820-6 · Cited by 650
Bradykinin receptors: Pharmacological properties and biological roles
Hall, J. M. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90016-s · Cited by 451
Morris, H. R., Paxton, T., Dell, A., Langhorne, J., Berg, M., Bordoli, R. S., Hoyes, J., & Bateman, R. H. (1996) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(19960610)10:8<889::aid-rcm615>3.0.co;2-f · Cited by 446
Kinin Formation: Mechanisms and Role in Inflammatory Disorders
Proud, D., & Kaplan, A. P. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.000405 · Cited by 410
Marceau, F. (1995) · Immunopharmacology · doi:10.1016/0162-3109(95)00011-h · Cited by 376
Complement Activation and Hypersensitivity Reactions to Dialysis Membranes
Hakim, R. M., Breillatt, J., Lazarus, J. M., & Port, F. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410043111403 · Cited by 342
(1988) · Catalysis Today · doi:10.1016/0920-5861(88)80006-3 · Cited by 257
Zinc Metalloproteases In Health And Disease
(1996) · CRC Press eBooks · doi:10.1201/9781482272765 · Cited by 221
Research works printed but not linked: 5
- Bhoola, 1992, Bioregulation of kinins, Pharmacol Rev, 44, 1
- Blais C Jr, Rouleau JL, Brown NJ, Lepage Y, Spence D, Munoz C, Friborg J, Geadah D, Gervais N, Adam A. Serum metabolism of bradykinin (BK) and des-Arg9-BK in patients with ACE inhibitor (ACEI)-associated angioedema (AE). The Fifteenth International Conference on Kinins, Kinin ’98 Nara, October 19–24, 1998, Nara, Japan [Abstract P-X-21].
- Ersahin, 1998, Cardioprotective effects of the aminopeptidase P inhibitor, apstatin, FASEB J, 12, A409
- Ryan, 1994, Characterization of rat pulmonary vascular aminopeptidase P in vivo, J Pharmacol Exp Ther, 269, 941
- Vanhoof, 1992, Proline-specific aminopeptidases, Agents Actions 38/II(Suppl.), 120
Cited by
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Agostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
The Kallikrein-Kinin System: Current and Future Pharmacological Targets
Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.srj05001x · Cited by 457
Self-citationBradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma
Cyr, M., Lepage, Y., Blais, C., Gervais, N., Cugno, M., Rouleau, J.-L., & Adam, A. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h275 · Cited by 160
Self-citationCilia La Corte, A. L., Carter, A. M., Rice, G. I., Duan, Q. L., Rouleau, G. A., Adam, A., Grant, P. J., & Hooper, N. M. (2011) · Human Mutation · doi:10.1002/humu.21579 · Cited by 154
Self-citation
Metadata
- Authors
- Blais, C., Marc–Aurèle, J., Simmons, W. H., Loute, G., Thibault, P., Skidgel, R. A., & Adam, A.
- Affiliations
- Université de Montréal (CA)
- Loyola University Chicago (US)
- National Research Council Canada (CA)
- University of Illinois Chicago (US)
- Corresponding author
- Adam, Albert
- Venue
- Peptides
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 20
- Issue
- 4
- Pages
- 421-430
- ISSN
- 0196-9781 (ISSN-L)
- OpenAlex
- W2004587229
- Cited by
- 60
- References
- 58
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2016: 1 · 2015: 2 · 2013: 2 · 2012: 2
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Peptides (publishedVersion)
- PubMed (publishedVersion)
- NPARC (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- des-Arg9-bradykinin, bradykinin metabolism, hemodialysis, hypersensitivity, ACE inhibitors, aminopeptidase P, enalaprilat, AN69 membrane, serum enzyme activity
- MeSH terms
- Acrylic Resins, Acrylonitrile, Aged, Aminopeptidases, Angiotensin-Converting Enzyme Inhibitors, Lysine Carboxypeptidase, Bradykinin, Female, Renal Dialysis, Humans, Hypersensitivity, Peptidyl-Dipeptidase A, Male, Membranes, Artificial, Middle Aged, Enalaprilat, Receptors, Bradykinin, Receptor, Bradykinin B1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. https://app.cochat.ai/papers/10.1016/s0196-9781(99)00020-0
- The paper
- Blais, C., Marc–Aurèle, J., Simmons, W. H., Loute, G., Thibault, P., Skidgel, R. A., & Adam, A. (1999). Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides. https://doi.org/10.1016/s0196-9781(99)00020-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.